Kenvue Execs, J&J Face 2nd Investor Action Over FDA Probe
By Corey Rothauser · January 19, 2024, 8:20 PM EST
Kenvue investors who bought into the multibillion-dollar pharmaceutical company's May 2023 initial public offering have named its executives and former parent company Johnson & Johnson in a proposed class action concerning...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login